Pediatric Wilson's Disease: Phenotypic, Genetic Characterization and Outcome of 182 Children in France

Archive ouverte

Couchonnal, Eduardo | Lion-Francois, Laurence | Guillaud, Olivier | Habes, Dalila | Debray, Dominique | Lamireau, Thierry | Broue, Pierre | Fabre, Alexandre | Vanlemmens, Claire | Sobesky, Rodolphe | Gottrand, Frederic | Bridoux-Henno, Laure | Dumortier, Jerome | Belmalih, Abdelouahed | Poujois, Aurelia | Jacquemin, Emmanuel | Brunet, Anne Sophie | Bost, Muriel | Lachaux, Alain

Edité par CCSD ; Lippincott, Williams & Wilkins -

International audience. OBJECTIVES: To describe a cohort of Wilson's disease (WD) paediatric cases, and to point out the diagnostic particularities of this age group and the long-term outcome. METHODS: Clinical data of 182 paediatric patients included in the French WD national registry from 01/03/1995 to 01/06/2019 were gathered. RESULTS: Diagnosis of WD was made at a mean age of 10.7 ± 4.2 years (range 1-18 years). At diagnosis, 154 patients (84.6%) had hepatic manifestations, 19 (10.4%) had neurological manifestations, and 9 patients (4.9%) were asymptomatic. The p.His1069Gln mutation was the most frequently encountered (14% of patients).Neurological patients were diagnosed at least one year after they presented their first symptoms. At diagnosis, the median urinary copper excretion (UCE) was 4.2 μmol/24 hours (0.2-253). The first-line treatment was D-penicillamine (DP) for 131 (72%) patients, zinc salts for 24 (13%) patients, and Trientine for 17 (9%) patients. Liver transplantation was performed in 39 (21.4%) patients, for hepatic indications in 33/39 patients or for neurological deterioration in 6/39 patients, mean UWDRS of the latter went from 90 ± 23.1 before LT to 26.8 ± 14.1 (p < 0.01) after a mean follow-up of 4.3 ± 2.5 years. Overall survival rate at 20 years of follow-up was 98%, patient and transplant-free combined survival was 84% at 20 years. CONCLUSION: Diagnosis of WD can be challenging in children, particularly at early stages of liver disease and in case of neurological presentation; hence the support of clinical scores and genetic testing is essential. Diagnosis at early stages and proper treatment ensure excellent outcomes, subject to good long-term treatment compliance. LT is a valid option for end-stage liver disease not responding to treatment and can be discussed for selected cases of neurological deterioration.

Consulter en ligne

Suggestions

Du même auteur

Corrigendum to "ATP7B variant spectrum in a French pediatric Wilson disease cohort" [Eur. J. Med. Genet. 64(10) (2021) 104305]

Archive ouverte | Couchonnal, Eduardo | CCSD

International audience

ATP7B variant spectrum in a French pediatric Wilson disease cohort

Archive ouverte | Couchonnal, Eduardo | CCSD

International audience. BACKGROUND/AIM: The spectrum of ATP7B variants varies significantly according to geographic distribution, and there is insufficient data on the variants observed in the French population. MET...

Long term results of liver transplantation for Wilson's disease: experience in France

Archive ouverte | Guillaud, Olivier | CCSD

International audience. BACKGROUND & AIMS: Liver transplantation (LT) is the therapeutic option for severe complications of Wilson's disease (WD). We aimed to report on the long-term outcome of WD patients following...

Chargement des enrichissements...